Jinan, China

Yutao Xue

This inventor holds 2 USPTO granted patents. Top assignee: Apotex Pharmachem Inc.. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutao Xue. Retrieved from https://idiyas.com/inventor/yutao-xue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2011-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yutao Xue: Innovator in Pharmaceutical Chemistry

Introduction

Yutao Xue is a notable inventor based in Jinan, China, recognized for his contributions to pharmaceutical chemistry. He has been instrumental in developing innovative methods for synthesizing important compounds used in medicine.

Latest Patents

Yutao Xue holds two patents related to the preparation of Efavirenz, a critical antiretroviral medication. His latest patents detail a process for synthesizing Efavirenz, which involves cyclizing a specific compound in the presence of a first base and a haloformate. These patents not only describe the methods but also introduce novel compounds that are utilized in these processes.

Career Highlights

Yutao Xue is currently employed at Apotex Pharmachem Inc., where he continues to advance his research in pharmaceutical development. His work has significantly impacted the field, particularly in the synthesis of complex organic compounds.

Collaborations

Yutao collaborates with talented individuals in his field, including Bo Chen and Zhi-Xian Wang, who contribute to his innovative projects and research endeavors.

Conclusion

Yutao Xue's work exemplifies the importance of innovation in pharmaceutical chemistry, particularly in the development of essential medications. His patents and collaborations highlight his commitment to advancing medical science through inventive solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…